These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 20852438

  • 1. Measurement of adherence to brimonidine therapy for glaucoma using electronic monitoring.
    Hermann MM, Bron AM, Creuzot-Garcher CP, Diestelhorst M.
    J Glaucoma; 2011 Oct; 20(8):502-8. PubMed ID: 20852438
    [Abstract] [Full Text] [Related]

  • 2. Adherence with brimonidine in patients with glaucoma aware and not aware of electronic monitoring.
    Hermann MM, Papaconstantinou D, Muether PS, Georgopoulos G, Diestelhorst M.
    Acta Ophthalmol; 2011 Jun; 89(4):e300-5. PubMed ID: 21106046
    [Abstract] [Full Text] [Related]

  • 3. Adherence with topical glaucoma medication monitored electronically the Travatan Dosing Aid study.
    Okeke CO, Quigley HA, Jampel HD, Ying GS, Plyler RJ, Jiang Y, Friedman DS.
    Ophthalmology; 2009 Feb; 116(2):191-9. PubMed ID: 19084273
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Dorzolamide/timolol combination versus concomitant administration of brimonidine and timolol: six-month comparison of efficacy and tolerability.
    Sall KN, Greff LJ, Johnson-Pratt LR, DeLucca PT, Polis AB, Kolodny AH, Fletcher CA, Cassel DA, Boyle DR, Skobieranda F.
    Ophthalmology; 2003 Mar; 110(3):615-24. PubMed ID: 12623832
    [Abstract] [Full Text] [Related]

  • 9. [Clinical efficacy of 0.2% brimonidine in patients with open-angle glaucoma or ocular hypertension].
    Shi JM, Jiang YQ.
    Hunan Yi Ke Da Xue Xue Bao; 2002 Jun 28; 27(3):263-6. PubMed ID: 12575311
    [Abstract] [Full Text] [Related]

  • 10. Meta-analysis of 24-hour intraocular pressure studies evaluating the efficacy of glaucoma medicines.
    Stewart WC, Konstas AG, Nelson LA, Kruft B.
    Ophthalmology; 2008 Jul 28; 115(7):1117-1122.e1. PubMed ID: 18082886
    [Abstract] [Full Text] [Related]

  • 11. Twenty-four-hour efficacy of the brimonidine/timolol fixed combination versus therapy with the unfixed components.
    Konstas AG, Katsimpris IE, Kaltsos K, Georgiadou I, Kordelou A, Nelson LA, Stewart WC.
    Eye (Lond); 2008 Nov 28; 22(11):1391-7. PubMed ID: 17571086
    [Abstract] [Full Text] [Related]

  • 12. Brimonidine tartrate 0.15%, dorzolamide hydrochloride 2%, and brinzolamide 1% compared as adjunctive therapy to prostaglandin analogs.
    Bournias TE, Lai J.
    Ophthalmology; 2009 Sep 28; 116(9):1719-24. PubMed ID: 19592108
    [Abstract] [Full Text] [Related]

  • 13. Determinants of medication adherence to topical glaucoma therapy.
    Dreer LE, Girkin C, Mansberger SL.
    J Glaucoma; 2012 Sep 28; 21(4):234-40. PubMed ID: 21623223
    [Abstract] [Full Text] [Related]

  • 14. Comparison of ocular hypotensive actions of fixed combinations of brimonidine/timolol and dorzolamide/timolol.
    García-Feijoó J, Sáenz-Francés F, Martínez-de-la-Casa JM, Méndez-Hernández C, Fernández-Vidal A, Calvo-González C, García-Sánchez J.
    Curr Med Res Opin; 2010 Jul 28; 26(7):1599-606. PubMed ID: 20429818
    [Abstract] [Full Text] [Related]

  • 15. Adherence improvement in Dutch glaucoma patients: a randomized controlled trial.
    Beckers HJ, Webers CA, Busch MJ, Brink HM, Colen TP, Schouten JS, Dutch Adherence Study Group.
    Acta Ophthalmol; 2013 Nov 28; 91(7):610-8. PubMed ID: 23025424
    [Abstract] [Full Text] [Related]

  • 16. A randomized trial of brimonidine versus timolol in preserving visual function: results from the Low-Pressure Glaucoma Treatment Study.
    Krupin T, Liebmann JM, Greenfield DS, Ritch R, Gardiner S, Low-Pressure Glaucoma Study Group.
    Am J Ophthalmol; 2011 Apr 28; 151(4):671-81. PubMed ID: 21257146
    [Abstract] [Full Text] [Related]

  • 17. Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medications.
    Fechtner RD, Godfrey DG, Budenz D, Stewart JA, Stewart WC, Jasek MC.
    Cornea; 2010 Jun 28; 29(6):618-21. PubMed ID: 20386433
    [Abstract] [Full Text] [Related]

  • 18. Risk factors for visual field progression in the low-pressure glaucoma treatment study.
    De Moraes CG, Liebmann JM, Greenfield DS, Gardiner SK, Ritch R, Krupin T, Low-pressure Glaucoma Treatment Study Group.
    Am J Ophthalmol; 2012 Oct 28; 154(4):702-11. PubMed ID: 22835512
    [Abstract] [Full Text] [Related]

  • 19. A randomized, investigator-masked, 4-week study comparing timolol maleate 0.5%, brinzolamide 1%, and brimonidine tartrate 0.2% as adjunctive therapies to travoprost 0.004% in adults with primary open-angle glaucoma or ocular hypertension.
    Reis R, Queiroz CF, Santos LC, Avila MP, Magacho L.
    Clin Ther; 2006 Apr 28; 28(4):552-9. PubMed ID: 16750466
    [Abstract] [Full Text] [Related]

  • 20. Diurnal and nocturnal effects of brimonidine monotherapy on intraocular pressure.
    Liu JH, Medeiros FA, Slight JR, Weinreb RN.
    Ophthalmology; 2010 Nov 28; 117(11):2075-9. PubMed ID: 20663566
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.